Nuvalent (NUVL) Change in Accured Expenses (2020 - 2026)

Nuvalent (NUVL) reported Change in Accured Expenses of -$2.1 million for Q1 2026, down 471.85% on a YoY basis from $573618.6 in Q1 2025, and up 65.79% quarter-over-quarter from -$6.2 million in Q4 2025.

Nuvalent (NUVL) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Nuvalent has reported Change in Accured Expenses for 7 years, with the latest figure at -$2.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses fell 471.85% year-over-year to -$2.1 million; the trailing twelve-month figure through Mar 2026 stood at $9.7 million (down 66.02% YoY), and the FY2025 full-year result was $11.5 million, down 57.34% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$2.1 million, up from -$6.2 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $13.7 million in Q4 2024, with the low at -$6.2 million in Q4 2025.
  • Historically, Change in Accured Expenses has averaged $3.0 million across 5 years, with a median of $2.5 million in 2023.
  • Annual changes were most pronounced in 2023 — Change in Accured Expenses jumped 5382.35% — and 2026, when it plunged 471.85%.
  • Nuvalent's Change in Accured Expenses stood at $4.5 million in 2022, then decreased by 14.03% to $3.8 million in 2023, then surged by 257.18% to $13.7 million in 2024, then tumbled by 145.35% to -$6.2 million in 2025, then jumped by 65.79% to -$2.1 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$2.1 million (Q1 2026), -$6.2 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 931,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 644,700.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.71 Bn 91.71 Bn - -
10 Nuvalent 9.70 Bn 9.70 Bn - -2.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.13 Mn
Mar 31, 2026 -2.13 Mn
Dec 31, 2025 -6.24 Mn
Dec 31, 2025 -6.24 Mn
Sep 30, 2025 5.23 Mn
Sep 30, 2025 5.23 Mn
Jun 30, 2025 12.84 Mn
Jun 30, 2025 12.84 Mn
Mar 31, 2025 -373,000.00
Mar 31, 2025 -373,000.00
Dec 31, 2024 13.75 Mn
Dec 31, 2024 13.75 Mn
Sep 30, 2024 4.25 Mn
Sep 30, 2024 4.25 Mn
Jun 30, 2024 10.91 Mn
Jun 30, 2024 10.91 Mn
Mar 31, 2024 -2.05 Mn
Mar 31, 2024 -2.05 Mn
Dec 31, 2023 3.85 Mn
Dec 31, 2023 3.85 Mn